WuXi PharmaTech to Participate in Upcoming Investor Conferences |
|
By: WuXi PharmaTech (Cayman) Inc. Posted: 2009-09-10 02:15:06 |
|
WuXi PharmaTech (Cayman) Inc. (NYSE: WX) today announced that Dr. Ge Li, the Company's Chairman and Chief Executive Officer, will participate at the Morgan Stanley Global Healthcare Unplugged Conference in New York on Tuesday, September 15, 2009, at 11:30 am Eastern Daylight Savings Time, and will present at the Bank of America Merrill Lynch Global Healthcare Conference in London on Thursday, September 17, 2009, at 11:20 am GMT/6:20 am Eastern Daylight Savings Time.
The Company will broadcast its participation at the Morgan Stanley Conference. The public may access the broadcast through the Investor Relations section of the Company's web site. About WuXi PharmaTech WuXi PharmaTech is a leading pharmaceutical, biotechnology, and medical device R&D outsourcing company, with operations in China and the United States. As a research-driven and customer-focused company, WuXi PharmaTech provides a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process. WuXi PharmaTech's services are designed to assist its global partners in shortening the cycle and lowering the cost of drug and medical device R&D. WuXi PharmaTech's operating subsidiaries are known as WuXi AppTec. For more information, please contact: Ronald Aldridge Director of Investor Relations WuXi PharmaTech (Cayman) Inc. Tel: +1-201-585-2048 |
| Trackback url: https://press.abc-directory.com/press/5124 |